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Abstract A concise organocatalytic method for the facile synthesis of
some novel 1′H-spiro[cycloalkyl-1,2′-quinazolin]-4′(3′H)-ones via a
one-pot, three-component condensation of isatoic anhydride, aryl or
aliphatic amines and a cyclic ketone is described.
Key words spiro compounds, quinazolinones, isatoic anhydride,
amines, cycloalkanones, multicomponent reactions
The exploration of synthetic efficiency while minimiz-
ing needless synthetic steps is key to the synthesis of com-
plex organic skeletons.1 One-step synthetic strategies are
increasingly used to access drug-like molecules.2 Specifical-
ly, heterocyclic frameworks bearing spiro centers possess
structural rigidity resulting from conformational restric-
tion, and they have consequently received attention due to
their enhanced activities against a number of pharmacolog-
ical targets.3
Spiroquinazolinones and their derivatives constitute a
privileged class of fused heterocycles, as they possess nota-
ble biological properties, especially antimicrobial activi-
ties.4 Such scaffolds have been explored as core structures
and have been extensively studied in many bioactive natu-
ral and synthetic molecules.5 Quinazolinones present nu-
merous biological actions, such as antitumor,6,7 antifibrilla-
tory,8 antidepressant,9 analgesic,10 diuretic,11 antihista-
mine,12 vasodilatory,13 antihypertensive,14 CNS-stimulant,15
tranquilizing,16 anxiolytic,17 and plant-growth-regulating18
activities. In addition, quinazolin-4(3H)-ones are useful
synthetic precursors.19–23 In continuation of our interest in
the design and synthesis of heterocyclic candidates,24 we
describe an efficient and scalable cascade strategy for the
synthesis of diversely functionalized 1′H-spiro[cycloalkyl-
1,2′-quinazolin]-4′(3′H)-one derivatives through a one-pot
condensation of isatoic anhydride, an aryl or aliphatic
amine, and a cyclic ketone in the presence of a catalytic
amount of acetic acid.
We started our study by investigating the 4-toluenesul-
fonic acid (PTSA)-catalyzed three-component reaction of
aniline (1a), isatoic anhydride (2), and cyclohexanone (3) as
model substrates in ethanol at reflux temperature. We
found that the desired product 4a was obtained in 51% yield
after heating at reflux for two hours. In attempts to increase
the reaction efficiency, we studied sulfamic acid and acetic
acid as catalysts (Table 1, entries 2–4). From these observa-
tions, it was clear that acetic acid (20 mol%) gave the best
yield (91%) in the shortest reaction time (entry 4). Subse-
quently, we screened a range of polar solvents (ethanol,
methanol, acetonitrile, and propan-2-ol) (entries 4–7) and
we found that methanol was the most efficient solvent for
Table 1  Optimization of Reaction Conditions for Synthesis of Spiro 
Product 4aa
Entry Catalyst (mol %) Solvent Time (min) Yieldb (%)
 1 – EtOH 180 trace
 2 PTSA (20) EtOH 120 51
 3 NH2SO3H (20) EtOH 120 57
 4 AcOH (20) EtOH  75 91
 5 AcOH (20) MeOH  60 94
 6 AcOH (20) MeCN 120 84
 7 AcOH (20) i-PrOH 120 79
 8 AcOH (5) MeOH  90 83
 9 AcOH (10) MeOH  60 93
10 AcOH (15) MeOH  60 94
a Reaction conditions: isatoic anhydride (2; 3 mmol), aniline (1a; 3 mmol), 
cyclohexanone (3; 3 mmol), solvent (10 mL), catalyst, reflux.
b Isolated yield.© Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–F































l.this condensation, affording the desired spiro product 4a in
94% yield (entry 5). Screening the quantity of the catalyst
showed that a yield of 93% was obtained by using 10 mol%
of acetic acid (entry 9). We also attempted to reduce the re-
action temperature from reflux to ambient temperature,
but the reaction was sluggish and the yield decreased (not
shown). Hence, the optimal conditions were determined to
be refluxing methanol containing 10 mol% of acetic acid as
the catalyst.
After the optimization studies, the synthesis of a variety
of functionalized 1′H-spiro[cyclohexane-1,2′-quinazolin]-
4′(3′H)-ones25,26 was performed to explore the efficiency
and versatility of this method (Scheme 1), and the results
are presented in Table 2. Various aromatic amines bearing
either electron-withdrawing or electron-donating substitu-
ents successfully afforded the corresponding products 4b–j
in good to excellent yields (Table 2, entries 2–10). In con-
trast, aliphatic amines 1k and 1l (Table 2, entries 11 and 12)
provided only moderate yields, presumably due to their
higher nucleophilicity compared with aryl amines. The
products were characterized by means of 1H and 13C NMR
spectroscopy and by X-ray single-crystal analysis.
Scheme 1  Acetic acid-assisted three-component synthesis of 3′-aryl-
1′H-spiro[cyclohexane-1,2′-quinazolin]-4′(3′H)-ones
In the 1H NMR spectrum of compound 4b, as a represen-
tative example, the aliphatic protons (–CH2–) of the cyclo-
hexane moiety appeared as multiplets at δ = 0.91, 1.25,
1.55, and 2.04 ppm; the secondary amine (–NH–) proton
appeared as a singlet at δ = 7.01 ppm; and the aromatic
protons were observed as multiplets at δ = 6.68–7.65 ppm.
In the 13C NMR spectrum, the carbons in the cyclohexane
ring appeared as resonances at δ = 21.1, 24.0 and 34.5 ppm,
and the amide carbon (–CONX) exhibited as a peak at
δ = 162.8 ppm. Furthermore, the structures of compounds
4a (Figure 1) and 4e (Figure 2) were confirmed by single-
crystal X-ray analysis.27
To extend the scope of the reaction, we applied the opti-
mized protocol to the synthesis of 1′H-spiro[cyclopentane-
1,2′-quinazolin]-4′(3′H)-ones by reaction with cyclopenta-
none (5; Scheme 2). Aromatic amines 1a–j bearing various
functional groups at various positions reacted with isatoic
anhydride (2) smoothly in the presence of cyclopentanone
(5), and the corresponding targets (6a–j) were obtained.
The results are summarized in Table 3.
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a Reaction conditions: isatoic anhydride (2; 3 mmol), amine 1 (3 mmol), 
cyclohexanone (3; 3 mmol), AcOH (10 mol%), MeOH (10 mL), reflux.
b Isolated yield.





















































 4 45 94
 5 45 95
 6 85 90
 7 50 92
 8 80 89
 9 90 86
10 90 85
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l.The 1H NMR spectrum of compound 6b showed multi-
plets at δ = 1.43, 1.71, and 1.89 ppm corresponding to the
aliphatic protons of the cyclopentane group. The secondary
amine (–NH–) proton appeared as a singlet at δ = 6.93 ppm,
and the aromatic protons appeared as multiplets at
δ = 6.69–7.67 ppm. In the 13C NMR spectrum, the amide
carbon (–CONX) was evident as a resonance at δ = 163.0
ppm.29 Moreover, the structure of 6e was confirmed by sin-
gle-crystal X-ray analysis (Figure 3).
Figure 3  ORTEP of compound 6e (CCDC 1543283)28
Finally, we examined the reaction with benzene-1,4-di-
amine (7) instead of an aromatic monoamine (Scheme 3),
and this pseudo-five-component reaction led to the novel
bis{1′H-spiro[cycloalkane-1,2′-quinazolin]-4′(3′H)-ones} 8
and 9 in good yields. Their structures were confirmed by 1H
and 13C NMR spectroscopic analyses.
In conclusion, we have disclosed an efficient and con-




a Reaction conditions: isatoic anhydride (2; 3 mmol), amine (1; 3 mmol), 
cyclopentanone (5; 3 mmol) AcOH (10 mol%), MeOH (10 mL), reflux.
b Isolated yields.
















Figure 1  ORTEP of compound 4a (CCDC 1543174)28


















1a–j 2 5 6a–j
Figure 2  ORTEP of compound 4e (CCDC 1543282)28
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l.through a three-component reaction in the presence of a
catalytic amount of acetic acid. The method tolerates an ar-
ray of functional groups and has the advantages of mild re-
action conditions, short reaction times, experimental sim-
plicity, and excellent yields.
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Colorless crystals; yield: 914 mg (91%); mp 208–210 °C. 1H NMR
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ArH), 6.70 (s, 1 H, NH), 7.03 (m, 3 H, ArH), 7.27 (d, J = 6.8 Hz, 3 H,
ArH), 7.63 (t, J = 7.2 Hz, 1 H, ArH). 13C NMR (100 MHz, DMSO-
d6): δ = 21.1, 23.7, 24.0, 32.9, 34.5, 72.9, 115.1, 115.6, 117.1,
126.4, 127.5, 130.0, 132.9, 135.7, 145.5, 147.3, 162.8. Anal.
Calcd for C22H26N2O (334.45): C 79.0, H 7.84, N 8.38; Found: C
79.44, H 8.15, N 8.76.
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with an ω scan mode. Lorentz, polarization, and empirical
absorption corrections using spherical harmonics implemented
in the SCALE3 ABSPACK scaling algorithm were applied.30 The
structure was solved by direct methods and subsequently com-
pleted by difference Fourier recycling. Nonhydrogen atoms
were refined anisotropically by using the full-matrix least-
squares technique. Hydrogen atoms were found by difference
Fourier synthesis after four cycles of anisotropic refinement,
and refined as riding on the adjacent carbon atom with an indi-
vidual isotropic temperature factor equal to 1.2 times the value© Georg Thieme Verlag  Stuttgart · New York — Synlett 2017, 28, A–F































l.of equivalent temperature factor of the parent atom. Olex231
and SHELXS, SHELXL32 programs were used for all the calcula-
tions.
(28) CCDC 1543174, 1543282, and 1543283 contains the supple-
mentary crystallographic data for compounds 4a, 4e, and 6e,
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Colorless crystals; yield: 907 mg (94%); mp 244–246 °C. 1H NMR
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